Shopping Cart
Remove All
Your shopping cart is currently empty
LSD1/HDAC6-IN-1 is an orally active dual inhibitor targeting lysine specific demethylase 1 (LSD1) and histone deacetylase 6 (HDAC6), demonstrating promising anti-tumor activity, particularly valuable for multiple myeloma (MM) research [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $359 | Backorder | Backorder | |
| 10 mg | $578 | Backorder | Backorder | |
| 25 mg | $1,160 | Backorder | Backorder |
| Description | LSD1/HDAC6-IN-1 is an orally active dual inhibitor targeting lysine specific demethylase 1 (LSD1) and histone deacetylase 6 (HDAC6), demonstrating promising anti-tumor activity, particularly valuable for multiple myeloma (MM) research [1]. |
| In vitro | LSD1/HDAC6-IN-1 exhibits exceptional efficacy across various multiple myeloma (MM) cell lines[1]. |
| In vivo | LSD1/HDAC6-IN-1 demonstrates efficacy in the MM.1S xenograft model[1]. |
| Synonyms | LSD1/HDAC6-IN-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.